09.05.2023 • NewsIMCDchemicals distributorAllianz

IMCD Seals Two Acquisitions and a Distribution Deal

Rotterdam-based speciality chemicals distributor IMCD kicked off the month of May agreeing a major distribution partnership and two outright acquisitions.

In one of the deals, subsidiary IMCD Colombia widened its pharmaceuticals capabilities with the acquisition of Allianz Group International, a distributor of active pharmaceutical ingredients (APIs) supplying the Colombian market.

The Bogota-based company, with 25 employees and revenue of around €6.9 million last year, was one of the first Colombian distributors to specialize in APIs. It is certified for storage, sampling, dispensing and distribution of the ingredients on the Colombian market.

This acquisition, which is subject to customary closing conditions, is expected to be completed during the current month.

The Dutch distribution giant has also agreed to acquire all shares of KOI Products Solutions and Engineering. The company based in Petach Tikva, Israel, employd 13 people, reported revenue of more than € EUR 8 million in financial year 2022.

© IMCD
© IMCD

KOI Products Solutions, founded in 1986, prides itself on long-standing partnerships with what it says are some of the world’s leading suppliers of specialty products. The company predominantly supplies the composites, paint, cosmetics, coatings and ink markets.

In a straightforward strategic distribution deal, IMCD has signed on to offer German chemicals and plastics producer Evonik’s resins for medical technology. The contract, effective from May 1, covers all countries in the European Economic Area, the UK and Switzerland.

Evonik’s medical technology portfolio includes polyamide materials Vestamid Care ML and Vestamid Care ME, Trogamid Care MX, along with the PEEK-based Vestakeep Care and the PBT-based Vestodur polymer materials. These find application in medical tubing, dialysis parts, surgical instruments and inhalers, among other products.

Author: Dede Williams, Freelance Journalist

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.